NDC 51672-4046-01 - Enalapril Maleate and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-4046
- Requested NDC
- 51672-4046-01
- Package NDCs from labels
- 51672-4046-1, 51672-4046-3, 51672-4046-01
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries, Ltd.
- Effective date
- 2026-07-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Enalapril Maleate and Hydrochlorothiazide Tablets, USP | Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries, Ltd. | 2026-07-14 | HUMAN PRESCRIPTION DRUG LABEL |
| Enalapril Maleate and Hydrochlorothiazide Tablets, USP | NuCare Pharmaceuticals,Inc. | 2021-02-12 | HUMAN PRESCRIPTION DRUG LABEL |
| Enalapril Maleate and Hydrochlorothiazide - Rebel Distributors Corp | Rebel Distributors Corp | 2010-12-20 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-4046-1 | Enalapril Maleate and Hydrochlorothiazide | 100 in 1 BOTTLE | TABLET | 100 | 12 | |
| 51672-4046-3 | Enalapril Maleate and Hydrochlorothiazide | 1000 in 1 BOTTLE | TABLET | 1000 | 12 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-4046 | ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE TABLET [TARO PHARMACEUTICALS U.S.A., INC.] | 12 | Current NDC, Legacy NDC, 2 package rows | 20240509_7cb92cf2-46f2-4379-937c-168d230e43a4.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-4046-1 | EA - Each | 51672-4046 | 0843b439-9694-412b-a9b3-6db98999e827 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Medi-First Plus First Aid Eye Wash | WATER | Unifirst First Aid Corporation | d7ea80ca-b4a0-4476-8b50-b3425c6d456a | 2025-09-08 | Warnings | 059QF0KO0R |
| ECOLAB Eye Wash | PURIFIED WATER | ECOLAB Food Safety Specialties, Inc. | 4bcfa21a-791e-4d04-e054-00144ff88e88 | 2025-09-08 | Warnings | 059QF0KO0R |
| Physicians Care Eyewash | EYEWASH | Acme United Corporation | 3e239b12-9a75-339d-e063-6294a90a72ae | 2025-09-06 | Warnings | 059QF0KO0R |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | NorthStar Rx LLC | 25318baf-9c2f-458f-b9ea-f52dabca49af | 2025-09-06 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| omeprazole and sodium bicarbonate | OMEPRAZOLE, SODIUM BICARBONATE | Meijer Distribution Inc | bb7c1c5d-b915-42f5-a5a2-5f61b088028d | 2025-09-05 | Warnings | 8MDF5V39QO |
| Powder | TITANIUM DIOXIDE | Oxygen Development LLC | 08b52f29-c1a0-c673-e063-6294a90a9a7a | 2025-09-05 | Warnings | 1K09F3G675 |
| Powder | TITANIUM DIOXIDE | Oxygen Development LLC | 08b8003f-40be-3380-e063-6294a90a4f6b | 2025-09-05 | Warnings | 1K09F3G675 |
| Polyethylene Glycol 3350 and electrolytes - Unflavored | POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES - UNFLAVORED | Strides Pharma Science Limited | 48c741a9-9039-4fdb-a875-86d4ea968282 | 2025-09-05 | Warnings, Adverse reactions | 8MDF5V39QO |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 6b7f96c3-daf4-4029-a96b-baa37add0edb | 2025-09-05 | Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 0e015b9a-0ac1-4ec3-bbe7-7a672d30e1f4 | 2025-09-04 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 8d56b5db-e72d-4f09-aed4-09e65a27e9ff | 2025-09-04 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Irbesartan and Hydrochlorothiazide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Macleods Pharmaceuticals Limited | 1898f438-4571-4aab-ae06-9bf1aabf0486 | 2025-09-02 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Sodium Bicarbonate 10 GR (650 MG) | SODIUM BICARBONATE | Advanced Rx LLC | 634e8d52-6d04-42f9-98f6-2634473b5dfd | 2025-09-01 | Warnings | 8MDF5V39QO |
| Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride - Unflavored | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE - UNFLAVORED | Strides Pharma Science Limited | 37c111ec-5b62-42b9-bbb2-3b0c530e34c9 | 2025-09-01 | Warnings, Adverse reactions | 8MDF5V39QO |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | be81ba65-c434-4287-97d3-cd11d6031636 | 2025-09-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Sodium Bicarbonate | SODIUM BICARBONATE | ProPharma Distribution | 3d71b046-3e0b-054a-e063-6294a90a563a | 2025-08-28 | Warnings, Adverse reactions | 8MDF5V39QO |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | AvKARE | e78b2195-a2da-3d03-e053-2a95a90a7d56 | 2025-08-28 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Sterile Water | WATER INJECTION | Henry Schein, Inc. | 3501952b-b556-4d5e-b81b-5c35ff87b475 | 2025-08-28 | Warnings, Adverse reactions | 059QF0KO0R |
| Olmesartan medoxomil and hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Camber Pharmaceuticals, Inc. | d421f352-9500-4d3e-8bc3-0cdcc2050514 | 2025-08-26 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | 67bedecc-f758-4bc6-82c5-7d428cbbbd9b | 2025-08-22 | Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.